First steps towards price transparency: comparability of online out-of-pocket tools from Australian private health funds
Kelsey Chalmers
A C , Adam G. Elshaug A B and Shaun Larkin A
A Menzies Centre for Health Policy, Charles Perkins Centre, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia, 2006. Email: elshaug@sydney.edu.au; shaun.larkin@sydney.edu.au
B Center for Health Policy and USC-Brookings Schaeffer Initiative for Health Policy, The Brookings Institution, Washington DC, USA, 20036.
C Corresponding author. Email: kelsey.chalmers@sydney.edu.au
Australian Health Review 44(3) 347-354 https://doi.org/10.1071/AH19109
Submitted: 9 May 2019 Accepted: 8 July 2019 Published: 13 November 2019
Journal Compilation © AHHA 2020 Open Access CC BY-NC-ND
Abstract
Objective The aims of this study were to compare and contrast the information three Australian private health insurance funds (HCF, Bupa and Medibank) have provided on their online out-of-pocket cost tools and to consider the implications this has for price transparency in Australia.
Methods Website data were downloaded from HCF, Bupa and Medibank on 18 February 2019. The information and statistics provided on these pages were reviewed, and the procedures compared across funds if their pages had referred to the same Medicare Benefits Schedule (MBS) item(s). Information was extracted regarding descriptions of the claims data used, the types of statistics provided, the out-of-pocket estimates, the total procedure cost, the MBS items referenced and the assumptions the funds described on their pages.
Results HCF specified the MBS items used to select the claims data for their estimates, whereas Bupa and Medibank only referred to common MBS items associated with the procedures. On average, HCF had 1.44 more MBS items listed than Bupa and 2.08 more than Medibank. The funds organised procedures differently, such as HCF providing separate cost estimates for vaginal, abdominal and keyhole hysterectomy compared with Medibank’s single estimate for hysterectomy costs.
Conclusions These funds have started to address the need for transparent out-of-pocket cost information, but the differences across these pages demonstrate complexities and the potential obfuscation of cost data.
What is known about the topic? Out-of-pocket costs are highly variable and patient ‘bill shock’ is an increasing concern in Australia. Private insurance funds have created online tools to share procedure cost estimates based on their claims data.
What does this paper add? This is the first review of Australian insurance funds’ price transparency tools. The cost information is difficult to interpret both within funds (for members) and across funds (for the system).
What are the implications for practitioners? Policy makers will need to consider the complexities and presentation options for cost estimates within the health system if they move ahead with a public price transparency tool. There is still a requirement for cost information that can facilitate price shopping across providers and funders.
References
[1] Sinaiko AD, Rosenthal MB. Increased price transparency in health care–challenges and potential effects. N Engl J Med 2011; 364 891–4.| Increased price transparency in health care–challenges and potential effects.Crossref | GoogleScholarGoogle Scholar | 21388306PubMed |
[2] Truong K. What’s next after the CMS price transparency ‘first step’. MedCity News 14 January 2019. Available at: https://medcitynews.com/2019/01/whats-next-after-the-cms-price-transparency-first-step/ [verified 8 March 2019].
[3] Blumenthal D. Why the cost of health care is so hard to understand – and what to do about it. The Wall Street Journal 7 February 2019. Available at: https://blogs.wsj.com/experts/2019/02/07/why-the-cost-of-health-care-is-so-hard-to-understand-and-what-to-do-about-it/ [verified 8 March 2019].
[4] The White House. Executive Order on improving price and quality transparency in American healthcare to put patients first. 2019. Available at https://www.whitehouse.gov/presidential-actions/executive-order-improving-price-quality-transparency-american-healthcare-put-patients-first/ [verified 8 March 2019].
[5] Freed GL, Allen AR. Variation in outpatient consultant physician fees in Australia by specialty and state and territory. Med J Aust 2017; 206 176–80.
| Variation in outpatient consultant physician fees in Australia by specialty and state and territory.Crossref | GoogleScholarGoogle Scholar | 28253468PubMed |
[6] Mehrotra A, Schleifer D, Shefrin A, Ducas AM. Defining the goals of health care price transparency: not just shopping around. NEJM Catalyst 26 June 2018. Available at: https://catalyst.nejm.org/health-care-price-transparency-goals/ [verified 8 March 2019].
[7] Australian Government Department of Health. Ministerial advisory committee on out-of-pocket costs. 2019. Available at http://www.health.gov.au/internet/main/publishing.nsf/Content/min-advisory-comm-out-of-pocket [verified 3 March 2019].
[8] Australian Prudential Regulation Authority. Operations of private health insurers annual report 2017/18. 2018. Available at: https://www.apra.gov.au/publications/operations-private-health-insurers-annual-report [verified 11 March 2019].
[9] Hunt G. National strategy to tackle specialist out of pocket costs. 2019. Available at: https://www.greghunt.com.au/national-strategy-to-tackle-specialist-out-of-pocket-costs/ [verified 8 March 2019].
[10] Royal Australasian College of Surgeons. Patient information and resources. 2015. Available at: https://www.surgeons.org/patient-information-resources#Fees%20for%20surgery [verified 11 October 2019].
[11] Desai S, Hatfield LA, Hicks AL, Chernew ME, Mehrotra A. Association between availability of a price transparency tool and outpatient spending. JAMA 2016; 315 1874–81.
| Association between availability of a price transparency tool and outpatient spending.Crossref | GoogleScholarGoogle Scholar | 27139060PubMed |
[12] Gourevitch RA, Desai S, Hicks AL, Hatfield LA, Chernew ME, Mehrotra A. Who uses a price transparency tool? Implications for increasing consumer engagement. Inquiry 2017; 54 46958017709104
| Who uses a price transparency tool? Implications for increasing consumer engagement.Crossref | GoogleScholarGoogle Scholar | 28523946PubMed |
